Charles Schwab’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-54,881	Closed	-$165K	–	3607
2025 Q1	$165K	Buy	54,881 +11,355	+26%	+$34.1K	﹤0.01%	3282
2024 Q4	$439K	Buy	43,526 +3,233	+8%	+$32.6K	﹤0.01%	3184
2024 Q3	$623K	Buy	+40,293	New	+$623K	﹤0.01%	3082